Quantcast
Home > Quotes > EXAS
EXAS

Exact Sciences Corporation Common Stock (EXAS) Quote & Summary Data

$96.95
*  
0.91
0.95%
Get EXAS Alerts
*Delayed - data as of May 21, 2019  -  Find a broker to begin trading EXAS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
111
Today's High / Low
$ 99.28 / $ 96.31
Share Volume
1,216,202
50 Day Avg. Daily Volume
1,796,589
Previous Close
$ 96.04
52 Week High / Low
$ 105.28 / $ 47.7817
Market Cap
12,520,004,721
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.32

Intraday Chart

Shares Traded

Share Volume:
1,216,202
50 Day Avg. Daily Volume:
1,796,589

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.77

Trading Range

The current last sale of $96.95 is 102.90% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 99.28 $ 105.28
 Low: $ 96.31 $ 47.7817

ETFs with EXAS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
6.15% Invesco DWA Healthcare Momentum ETF (PTH) +13.65 (21.01%)
5.34% VanEck Vectors Biotech ETF (BBH) +14.91 (14.37%)
3.62% First Trust Amex Biotech Index Fund (FBT) +15.64 (13.66%)
2.81% Invesco DWA NASDAQ Momentum ETF (DWAQ) +18.82 (19.87%)
2.79% First Trust Health Care AlphaDEX (FXH) +8.12 (12.69%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Exact Sciences Corporation (together with its subsidiaries, "Exact," "we," "us," "our" or the "Company") is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. We have developed an accurate, non-invasive, patient-friendly screening test called CologuardĀ® for the early detection of colorectal cancer and pre-cancer, and we are currently working on the development of additional tests for other types of cancer, with the goal of becoming a leader in cancer screening and diagnostics. Our Cologuard Test Colorectal cancer is the second leading cause of cancer deaths in the United States ("U.S.") and the leading cause of cancer deaths in the U.S. among non-smokers. Each year in the U.S.  ... More ...  



Risk Grade

Where does EXAS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 97.12
Open Date:
May 21, 2019
Close Price:
$ 96.95
Close Date:
May 21, 2019


Consensus Recommendation

Analyst Info